| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DUOL | Class A Common Stock | Options Exercise | $202K | +14K | +15.76% | $14.42 | 103K | Nov 1, 2024 | Direct | |
| transaction | DUOL | Class A Common Stock | Sale | -$641K | -2.2K | -2.14% | $291.41 | 101K | Nov 1, 2024 | Direct | F1, F2 |
| transaction | DUOL | Class A Common Stock | Sale | -$1.49M | -5.08K | -5.05% | $292.34 | 95.6K | Nov 1, 2024 | Direct | F1, F3 |
| transaction | DUOL | Class A Common Stock | Sale | -$823K | -2.81K | -2.93% | $293.34 | 92.8K | Nov 1, 2024 | Direct | F1, F4 |
| transaction | DUOL | Class A Common Stock | Sale | -$593K | -2.01K | -2.17% | $294.41 | 90.8K | Nov 1, 2024 | Direct | F1, F5 |
| transaction | DUOL | Class A Common Stock | Sale | -$259K | -877 | -0.97% | $295.76 | 89.9K | Nov 1, 2024 | Direct | F1, F6 |
| transaction | DUOL | Class A Common Stock | Sale | -$215K | -723 | -0.8% | $296.80 | 89.2K | Nov 1, 2024 | Direct | F1, F7 |
| transaction | DUOL | Class A Common Stock | Sale | -$89.2K | -300 | -0.34% | $297.33 | 88.9K | Nov 1, 2024 | Direct | F1, F8 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DUOL | Stock Option (Right to Buy) | Options Exercise | $0 | -14K | -49.25% | $0.00 | 14.4K | Nov 1, 2024 | Class A Common Stock | 14K | $14.42 | Direct | F9 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on May 22, 2024. |
| F2 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $290.93 to $291.84, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $291.94 to $292.93, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $292.94 to $293.91, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $293.98 to $294.96, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F6 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $295.15 to $296.09, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F7 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $296.23 to $296.97, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F8 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $297.27 to $297.45, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F9 | The shares subject to the option are fully vested and exercisable. |